Podcast
Play an AI-generated podcast conversation about this lesson
Questions and Answers
Which group of pSS patients has a significantly increased risk of lymphoproliferative disease?
Which group of pSS patients has a significantly increased risk of lymphoproliferative disease?
- Patients with normal C4 levels
- Patients without low complement C4 levels and/or palpable purpura (Type II)
- Patients with low complement C4 levels and/or palpable purpura (Type I) (correct)
- Patients with high-grade fever
Which group of pSS patients has the most severe extraglandular manifestations?
Which group of pSS patients has the most severe extraglandular manifestations?
- Patients with low complement C4 levels and/or palpable purpura (Type I) (correct)
- Patients with normal C4 levels
- Patients without low complement C4 levels and/or palpable purpura (Type II)
- Patients with high-grade fever
What characterizes the Type II form of pSS?
What characterizes the Type II form of pSS?
- High risk of lymphoproliferative disease
- Increased mortality rate
- Dominance by high-grade fever
- Low-risk with no increased risk of death (correct)
Which factor does NOT contribute to classifying a patient as Type I high-risk pSS?
Which factor does NOT contribute to classifying a patient as Type I high-risk pSS?
Signup and view all the answers
What distinguishes the clinical risks between Type I and Type II pSS patients?
What distinguishes the clinical risks between Type I and Type II pSS patients?
Signup and view all the answers
